These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32799428)

  • 1. Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer.
    Broes S; Saesen R; Lacombe D; Huys I
    Clin Transl Sci; 2021 Jan; 14(1):47-53. PubMed ID: 32799428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Mind the gap' between the development of therapeutic innovations and the clinical practice in oncology: A proposal of the European Organisation for Research and Treatment of Cancer (EORTC) to optimise cancer clinical research.
    Kempf E; Bogaerts J; Lacombe D; Liu L
    Eur J Cancer; 2017 Nov; 86():143-149. PubMed ID: 28987771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer research in the United States: A critical review of current status and proposal for alternative models.
    Kantarjian HM; Prat F; Steensma DP; Kurzrock R; Stewart DJ; Sekeres MA; Leveque J
    Cancer; 2018 Jul; 124(14):2881-2889. PubMed ID: 29757456
    [No Abstract]   [Full Text] [Related]  

  • 4. Current models, challenges and best practices for work conducted between European academic cooperative groups and industry.
    Stahel RA; Lacombe D; Cardoso F; Casali PG; Negrouk A; Marais R; Hiltbrunner A; Vyas M;
    ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32213534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries.
    Wilking N; Bucsics A; Kandolf Sekulovic L; Kobelt G; Laslop A; Makaroff L; Roediger A; Zielinski C
    ESMO Open; 2019; 4(6):e000550. PubMed ID: 31798977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Academia-industry partnerships: are we ready for new models of partnership?: the point of view of the EORTC, an academic clinical cancer research organisation.
    Lacombe D; Burock S; Meunier F
    Eur J Cancer; 2013 Jan; 49(1):1-7. PubMed ID: 23079476
    [No Abstract]   [Full Text] [Related]  

  • 7. Outlook: finding improved medicines: the role of academic-industrial collaboration.
    Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D
    Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational Research and Drug Development in Psoriasis by Collaborative Efforts of Academia and Industry.
    van de Kerkhof PCM
    J Invest Dermatol; 2020 Mar; 140(3):524-526. PubMed ID: 31945346
    [No Abstract]   [Full Text] [Related]  

  • 9. Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.
    Vassal G; Rousseau R; Blanc P; Moreno L; Bode G; Schwoch S; Schrappe M; Skolnik J; Bergman L; Bradley-Garelik MB; Saha V; Pearson A; Zwierzina H
    Eur J Cancer; 2015 Jan; 51(2):218-24. PubMed ID: 25434924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining association between cohesion and diversity in collaboration networks of pharmaceutical clinical trials with drug approvals.
    Lin G; Siddiqui S; Bernstein J; Martinez DA; Gardner L; Albright T; Igusa T
    J Am Med Inform Assoc; 2021 Jan; 28(1):62-70. PubMed ID: 33164100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflict of Interest, Conflicting Interests, and Effective Collaboration Between Academia and Industry on Preclinical and Clinical Cancer Research.
    Rothenburg ML; Johnson DH
    JAMA Oncol; 2017 Dec; 3(12):1621-1622. PubMed ID: 28687825
    [No Abstract]   [Full Text] [Related]  

  • 12. Pursuit of personalized anticancer therapy: leveraging collaboration between academia and the biotech/pharmaceutical industry.
    Buck E; Mulvihill M; Iwata KK
    Mt Sinai J Med; 2010; 77(4):358-65. PubMed ID: 20687181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the changing geographical pattern of international scientific collaborations through the prism of cities.
    Csomós G; Vida ZV; Lengyel B
    PLoS One; 2020; 15(11):e0242468. PubMed ID: 33196668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European LeukemiaNet: achievements and perspectives.
    Hehlmann R; Grimwade D; Simonsson B; Apperley J; Baccarani M; Barbui T; Barosi G; Bassan R; Béné MC; Berger U; Büchner T; Burnett A; Cross NC; de Witte TJ; Döhner H; Dombret H; Einsele H; Engelich G; Foà R; Fonatsch C; Gökbuget N; Gluckman E; Gratwohl A; Guilhot F; Haferlach C; Haferlach T; Hallek M; Hasford J; Hochhaus A; Hoelzer D; Kiladjian JJ; Labar B; Ljungman P; Mansmann U; Niederwieser D; Ossenkoppele G; Ribera JM; Rieder H; Serve H; Schrotz-King P; Sanz MA; Saussele S;
    Haematologica; 2011 Jan; 96(1):156-62. PubMed ID: 21048032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing gene and cell therapies for rare diseases: an opportunity for synergy between academia and industry.
    Mavilio F
    Gene Ther; 2017 Sep; 24(9):590-592. PubMed ID: 28485723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. University - industry collaborations: models, drivers and cultures.
    Ehrismann D; Patel D
    Swiss Med Wkly; 2015; 145():w14086. PubMed ID: 25658854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Setting a research agenda for vascular Ehlers-Danlos syndrome using a patient and stakeholder engagement model.
    Sage L; Russo ML; Byers PH; Demasi J; Morris SA; Puryear LN; Fulton DS; Shalhub S;
    J Vasc Surg; 2020 Oct; 72(4):1436-1444.e2. PubMed ID: 32115322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WORLD CANCER RESEARCH DAY: A Call to Action for a Coordinated International Research Effort to Prevent, Diagnose, and Treat Cancer.
    Puyol M; Seoane J; Aguilar E; Vozza LB; Orbe I; Crawford KH; Fernández A; Bray F; Johnson SE; Gopal S
    Clin Cancer Res; 2021 Feb; 27(4):963-966. PubMed ID: 33257425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing the challenge of intergroup studies in oncology: the EORTC experience. European Organisation for Research and Treatment of Cancer.
    Zurlo A; Therasse P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S169-72. PubMed ID: 11858988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
    Takebe T; Imai R; Ono S
    Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.